A detailed history of Nicholas Investment Partners, LP transactions in Rx Sight, Inc. stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 74,347 shares of RXST stock, worth $2.77 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
74,347
Previous 143,771 48.29%
Holding current value
$2.77 Million
Previous $8.65 Million 57.53%
% of portfolio
0.41%
Previous 1.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$40.78 - $57.04 $2.83 Million - $3.96 Million
-69,424 Reduced 48.29%
74,347 $3.67 Million
Q2 2024

Aug 07, 2024

BUY
$50.42 - $64.29 $3.79 Million - $4.83 Million
75,094 Added 109.34%
143,771 $8.65 Million
Q1 2024

May 13, 2024

BUY
$35.51 - $57.92 $435,459 - $710,272
12,263 Added 21.74%
68,677 $3.54 Million
Q4 2023

Feb 07, 2024

BUY
$20.91 - $40.9 $1.18 Million - $2.31 Million
56,414 New
56,414 $2.27 Million

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.03B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.